Financial Performance - The company's operating revenue for Q1 2023 was CNY 242,482,698.39, representing a year-on-year increase of 24.59%[5] - The net profit attributable to shareholders was CNY 25,809,325.59, showing a significant increase of 61.78% compared to the same period last year[5] - Total operating revenue for Q1 2023 was ¥242,482,698.39, an increase of 24.5% compared to ¥194,623,624.19 in Q1 2022[22] - Net profit for Q1 2023 reached ¥25,810,465.10, representing a 62.1% increase from ¥15,953,033.54 in Q1 2022[23] - The company reported a total profit of ¥28,221,207.79 for Q1 2023, compared to ¥15,920,241.26 in Q1 2022, marking a 77.1% increase[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,323,570,674.44, an increase of 4.90% from the end of the previous year[6] - The company's total liabilities reached ¥1,007,302,134.70, compared to ¥804,883,253.37 at the end of 2022, representing an increase of approximately 25.1%[17] - The total liabilities as of Q1 2023 amounted to ¥495,252,777.52, an increase of 34.6% from ¥367,812,253.61 in Q1 2022[22] - Non-current assets totaled ¥1,265,438,397.72, slightly up from ¥1,236,078,969.94, reflecting a growth of about 2.4%[17] Cash Flow - The net cash flow from operating activities was negative at CNY -68,366,905.25, primarily due to increased government subsidies received during the period[6] - In Q1 2023, the company's cash inflow from operating activities was CNY 200,558,064.49, a decrease of 16.06% compared to CNY 238,927,016.03 in Q1 2022[25] - The cash outflow from operating activities totaled CNY 268,924,969.74, down 28.43% from CNY 375,564,046.82 in the same period last year[25] - The net cash flow from operating activities was negative CNY 68,366,905.25, an improvement from negative CNY 136,637,030.79 in Q1 2022[25] - The company's cash and cash equivalents at the end of Q1 2023 stood at CNY 217,721,421.46, a decrease from CNY 444,461,401.56 at the beginning of the quarter[27] Research and Development - Research and development (R&D) expenses totaled CNY 13,733,030.41, which is an increase of 48.50% year-on-year, accounting for 5.66% of operating revenue[6] - Research and development expenses for Q1 2023 totaled ¥13,733,030.41, a rise of 48.1% from ¥9,247,965.09 in Q1 2022[22] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,529[10] - The largest shareholder, Pu Yilong, holds 35.80% of the shares, totaling 88,375,869 shares[11] Other Income and Gains - The company reported non-recurring gains of CNY 13,565,972.37, which included government subsidies and other income[8] - Other income for Q1 2023 was ¥7,508,990.65, significantly higher than ¥1,740,014.08 in Q1 2022[22] Equity and Earnings Per Share - The basic earnings per share (EPS) for the period was CNY 0.10, reflecting an increase of 11.11% compared to the previous year[6] - Earnings per share for Q1 2023 were ¥0.10, compared to ¥0.09 in Q1 2022[23] - The total equity attributable to shareholders reached ¥2,826,316,757.41, up from ¥2,800,507,431.82 in Q1 2022[22] Investment Activities - Investment cash outflow amounted to CNY 294,173,628.15, significantly higher than CNY 38,655,914.66 in Q1 2022[27] - The net cash flow from investing activities was negative CNY 294,171,761.49, compared to negative CNY 38,041,295.92 in the previous year[27]
隆达股份(688231) - 2023 Q1 - 季度财报